Abstracts and Articles

MASH

The summaries are free for public use. The Chronic Liver Disease Foundation will continue to add and archive summaries of articles deemed relevant to CLDF by the Board of Trustees and its Advisors.

1 01/01/2026

Accuracy and Reliability of an MR-Compatible Dorsiflexion Ergometer for Dynamic 31P-MRS: Comparison With a Clinical Dynamometer in Individuals With and Without Obesity.

Stouge Anders (A);Andersen Ole Emil (OE);Hansen Esben Søvsø Szocska (ESS);Rasmussen Cuno (C);Larsen Ryan Godsk (RG);Layec Gwenael (G);Miller Jack (J);Valkovič Ladislav (L);Kent Jane A (JA);Laustsen Christoffer (C);Bruun Jens Meldgaard (JM);Andersen Henning (H);Vaeggemose Michael (M)

2 12/02/2025

Effects of exercise interventions on metabolic and hepatic function markers in overweight or obese patients with MASLD: a systematic review and meta-analysis.

Chen Jiu (J);Wang Siji (S);Xin Xianyang (X);Xie Jun (J)

3 12/02/2025

Weight-related impairment in children and adolescents with overweight and obesity: A cross-sectional study on associations with sociodemographic characteristics and health-related quality of life.

Poulain Tanja (T);Grafe Nico (N);Kiess Wieland (W)

4 12/02/2025

CUN‑BAE predicts risk of metabolic dysfunction-associated steatotic liver disease: A prospective cohort study in non‑obese Chinese adults.

Wu Xueyan (X);Zhang Rong (R);Gan Shenglian (S);Zhou Haifeng (H);Yu Fang (F);Luo Jian (J)

5 12/02/2025

Obesity and Severe Obesity in Youth Before and During COVID-19.

Messiah Sarah E (SE);Guo Yujia (Y);Xie Luyu (L);Ernest Deepali K (DK);Steele Eurídice Martínez (EM);Neri Daniela (D);Sova McCabe Margaret E (ME);DeSantis Stacia M (SM);Cartwright Bethany R (BR);Lipshultz Steven E (SE);Barlow Sarah E (SE)

6 12/01/2025

[Effect of semaglutide on serum metabolomics in obese patients with type 2 diabetes mellitus complicated with metabolic-associated fatty liver disease].

Niu S (S);Wang C X (CX);Zhao Y B (YB);Wu D (D);Yang K L (KL)

7 12/01/2025

Physical sporting activity impact on long-term BMI trajectories in Dutch adults: a longitudinal observational study.

Lubbe Dirk (D);Gretschel Stephan (S);Otto Philipp (P);Elbelt Ulf (U)

8 12/01/2025

Liver fibrosis index and mortality in metabolic dysfunction-associated steatotic liver disease: a Korean cohort study.

Lee Yesung (Y);Lee Woncheol (W)

9 12/01/2025

Efficacy and safety of liraglutide in non-alcoholic fatty liver disease with or without type 2 diabetes: A systematic review and meta-analysis.

Kong Weihan (W);Fang Buwu (B);Xing Wei (W)

10 12/01/2025

Psychiatric Comorbidities and Weight Loss Recommendations in Bariatric Surgery Patients.

Dalrymple Kristy (K);Toba Cristina (C)

11 12/01/2025

Increasing Prevalence of Steatotic Liver Disease in a Japanese Health Checkup Population, 2004-2022.

Nakahata Yuki (Y);Miwa Takao (T);Obora Akihiro (A);Kojima Takao (T);Yagi Nobuaki (N);Shimizu Masahito (M)

12 12/01/2025

GLP-1RA and Liver Fibrosis Progression in MASLD and Type 2 Diabetes: Target Trial Emulation Using Propensity Score Matching.

Choi Jonggi (J);Kamath Tushar (T);Nguyen Vy H (VH);Przybyszewski Eric (E);Song Jiunn (J);Carroll Allison (A);Michta Megan (M);Almazan Erik (E);Simon Tracey G (TG);Chung Raymond T (RT)

13 11/29/2025

Developing a Comprehensive Approach for Managing Cardiorenal Metabolic Diseases (CRMD) in Saudi Arabia: Thinking beyond Single Disease-Literature Review and Multidisciplinary Consensus Report.

Alshaikh Abdulrahman (A);Alshehri Ali (A);Alzubaidi Lamya (L);Elbadawi Hussein (H);Alsaeed Abdulghani (A);Almehthel Mohammed (M);Aldahash Raed (R);Alsabaan Fahad (F);Alotaibi Metib (M);Alghamdi Khalid (K);Alamri Hussein (H);Bakhsh Abdulmohsen (A);Evans Marc (M);Issak Emad R (ER);Alsifri Saud (S)

14 11/29/2025

Adiposity and the first-onset of diagnosed mental illnesses: a population-based cohort study of 10 million UK adults.

Dong Xue (X);Aveyard Paul (P);Yang Xiaochen (X);Kivimaki Mika (M);Chen Shanquan (S);Firth Joseph (J);Drakesmith Cynthia Wright (CW);Gao Min (M)

15 11/28/2025

Effect of empagliflozin on liver fibrosis and steatosis in patients with type 2 diabetes and non-alcoholic fatty liver disease: a randomized clinical trial.

Erfanifar Azam (A);Nikpour Shahriar (S);Davoudi Zahra (Z);Jolfaei Pardis (P);Toreyhi Hossein (H);Mostafavi Nasab Seyedeh Naghmeh (SN)

16 11/28/2025

A prospective assessment of simple lymphatic drainage to prevent lower limb lymphedema in gynecological malignancies.

Utsugi Kuniko (K);Ishizuka Naoki (N);Seki Yukio (Y);Nomura Hidetaka (H);Fusegi Atsushi (A);Kanao Hiroyuki (H)

17 11/28/2025

Association of noninvasive tests of liver fibrosis with chronic kidney disease in MASLD: a systematic review and meta-analysis.

Sethasine Supatsri (S);Trakarnvanich Thananda (T);Ruamtawee Witchakorn (W);Treerasoradaj Nutachat (N);Susantitaphong Paweena (P)

18 11/28/2025

Diagnostic performance of ultrasound attenuation imaging in detecting hepatic steatosis.

Naghibi Hamed (H);Shakiba Madjid (M);Azizi Narges (N)